EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Antibody‒cell conjugates: A novel “off-the-shelf” modality bridging ADCs and CAR-T for cancer immunotherapy

Yifei Dai, Yujia Xie, Xiaojuan Ma, Dong Zhang, Jiao Yang, Kequan Lin, Aiping Chen, Weijie Qiang

Acta Pharmaceutica Sinica B · 2026-10 · 16 (10) · 6360-6377

DOI: 10.1016/j.apsb.2026.07.034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-10. Verfasst von Yifei Dai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yangtze River Delta Center for Drug Evaluation and Inspection of The National Medical Products Administration, Shanghai 201210, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Allogeneic cell therapyAntibody‒cell conjugatesCancer immunotherapyCarrier cellsClinical progressConstruction strategiesNon-genetic engineeringOff-the-shelf

Autor:innen und Institutionen

  • Yangtze River Delta Center for Drug Evaluation and Inspection of The National Medical Products Administration, Shanghai 201210, China.
  • Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
  • Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Dai, Y., Xie, Y., Ma, X., Zhang, D., Yang, J., Lin, K., Chen, A., & Qiang, W. (2026). Antibody‒cell conjugates: A novel “off-the-shelf” modality bridging ADCs and CAR-T for cancer immunotherapy. Acta Pharmaceutica Sinica B, 16(10), 6360-6377. https://doi.org/10.1016/j.apsb.2026.07.034

Vancouver

Dai Y, Xie Y, Ma X, Zhang D, Yang J, Lin K, et al. Antibody‒cell conjugates: A novel “off-the-shelf” modality bridging ADCs and CAR-T for cancer immunotherapy. Acta Pharmaceutica Sinica B. 2026;16(10):6360-6377. doi:10.1016/j.apsb.2026.07.034

BibTeX
@article{Dai2026,
  author = {Dai, Yifei and Xie, Yujia and Ma, Xiaojuan and Zhang, Dong and Yang, Jiao and Lin, Kequan and Chen, Aiping and Qiang, Weijie},
  title = {Antibody‒cell conjugates: A novel “off-the-shelf” modality bridging ADCs and CAR-T for cancer immunotherapy},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {6360--6377},
  doi = {10.1016/j.apsb.2026.07.034}
}
Kostenlos starten →